0000000000410153

AUTHOR

Andrea Rizzi

showing 3 related works from this author

Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma

2021

INTRODUCTION Asthma symptoms can be relieved through a maintenance treatment combining long-acting β2-agonist and inhaled corticosteroids (LABA/ICS). However, for patients with inadequately controlled asthma, the LABA/ICS combination might not be sufficient. Under these conditions, clinical guidelines recommend the administration of inhaled long-acting muscarinic antagonists (LAMA) as an add-on therapy to LABA/ICS to better control asthma and improve lung function. For nearly two decades, the only LAMA to be approved on the market has been tiotropium. AREAS COVERED We reviewed recent clinical studies evaluating the safety and efficacy of LABA/LAMA/ICS fixed dose combinations by searching Pu…

Pulmonary and Respiratory Medicinemedicine.medical_specialtycorticosteroidFixed-dose combinationLABAAsthma corticosteroid fixed dose combination ICS inhaler LABA LAMA once daily combination uncontrolled asthmaMuscarinic Antagonistsonce daily combinationQuinolonesSettore MED/10 - Malattie Dell'Apparato RespiratorioinhalerAdrenal Cortex HormonesInternal medicineAdministration InhalationImmunology and AllergyMedicineHumansfixed dose combinationAdrenergic beta-2 Receptor AgonistsAsthmaFluticasonebiologyInhalationuncontrolled asthmabusiness.industryInhalerPublic Health Environmental and Occupational HealthLAMALamamedicine.diseasebiology.organism_classificationGlycopyrrolateFluticasone-Salmeterol Drug CombinationAsthmarespiratory tract diseasesDrug CombinationsICSIndansIndacaterolSalmeterolbusinessMometasone Furoatehormones hormone substitutes and hormone antagonistsmedicine.drug
researchProduct

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

2021

SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. We conducted a planned sub-study and analysis from an international, multicentre, prospective cohort study of elective and emergency patients undergoing surgery during October 2020. Patients from all surgical specialties were included. The primary outcome measure was venous thromboembolism (pulmonary embolism or deep vein thrombosis) within 30 da…

Malepulmonary embolismInternationalitySettore MED/18 - CHIRURGIA GENERALEDeep veinVascular damage Radboud Institute for Health Sciences [Radboudumc 16]infectious diseasesCardiovascularSARS‐CoV‐2surgeryCOVID-19 ; SARS-CoV-2 ; deep vein thrombosis ; pulmonary embolism ; venous thromboembolismCohort StudiesPostoperative ComplicationsAnesthesiologyMedicine and Health SciencesProspective Studies610 Medicine & healthProspective cohort studyLung11 Medical and Health SciencesConfoundingHematologyMiddle AgedThrombosis17 Psychology and Cognitive SciencesCOVID-19; deep vein thrombosis; pulmonary embolism; SARS-CoV-2; venous thromboembolismPulmonary embolismCOVID-19; SARS-CoV-2; deep vein thrombosis; pulmonary embolism; venous thromboembolism.medicine.anatomical_structureCohortCOVID-19/complicationsPostoperative Complications/etiologyOriginal ArticleFemalePatient SafetyLife Sciences & BiomedicineCOVID-19; SARS-CoV-2; deep vein thrombosis; pulmonary embolism; venous thromboembolismHumanAdultmedicine.medical_specialtyAdolescentClinical Sciencesvenous thromboembolism610 Medicine & healthGlobalSurg CollaborativeVenous Thromboembolism/etiologydeep vein thrombosisNOCOVIDSurg CollaborativeYoung AdultMedicine General & InternalAge DistributionClinical ResearchCOVID‐19General & Internal MedicinemedicineHumansSex DistributionAgedScience & Technologybusiness.industrySARS-CoV-2PreventionNeurosciencesdeep vein thrombosiCOVID-19PneumoniaOdds ratioOriginal Articlesmedicine.diseaseSurgeryReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Prospective StudieGood Health and Well BeingAnesthesiology and Pain MedicineHuman medicinePostoperative ComplicationCohort StudiebusinessVenous thromboembolism[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Observation of the rare B(s)(0) + decay from the combined analysis of CMS and LHCb data.

2015

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported licence.-- et al.

fundamental particleCompact Muon Solenoidstandard model flavor changing neutral currentsradioisotope decayB physicGaussian methodMU(+)MU(-)Temel Bilimler (SCI)rare decay [B/s0]Elementary particleATLAS DETECTOR12.15.MmÇOK DİSİPLİNLİ BİLİMLERRARE B-MESON DECAYS7000 GeV-cms8000 GeV-cmsSettore ING-INF/01 - Elettronica01 natural sciences7. Clean energyddc:0702 CHARGED LEPTONSscattering [p p]High energy physics ; Experimental particle physics ; LHC ; CMS ; Standard ModelQC[Anahtar Kelime Yok]Large Hadron ColliderMedicine (all); Multidisciplinarystandard3. Good healthHigh Energy Physics - PhenomenologyCERN LHC CollFIS/01 - FISICA SPERIMENTALEpriority journalHiggs bosonScience & Technology - Other TopicsPARTICLE PHYSICSmass spectrum [dimuon]Protonviolationcolliding beams [p p]physicschemical analyzerMesonModels beyond the standard modelprobabilitymesonelectromagnetic radiationB/s0 --> muon+ muon-Nuclear physicsbranching ratio: measured [B0]SEARCHLeptonic semileptonic and radiative decays of bottom mesonRARE B-MESON DECAYS; MINIMAL FLAVOR VIOLATION; LHC; CMS DETECTOR; LHCb DETECTOR; SEARCH; MU(+)MU(-); B-S(0); B-0;B-MESON DECAYS; MINIMAL FLAVOR VIOLATION; 2 CHARGED LEPTONS; ATLAS; DETECTOR; SEARCH; MU(+)MU(-); B-S(0); B-0; COLLIDER; PARTICLE010306 general physicsScience & TechnologyMuonMULTIDISCIPLINARY SCIENCES010308 nuclear & particles physicsBranching fractionMeson Bnull hypothesisDoğa Bilimleri GenelElementary particlesLARGE HADRON COLLIDERHEPp(p)over-bar collisionsNATURAL SCIENCES GENERALrare decay [B0]13.20.HeMINIMAL FLAVOR VIOLATIONchemical analysisprecisionB0 --> muon+ muon-Física de partículesExperimental particle physicsleptonic decay [B0]Physics::Instrumentation and DetectorsPhysics beyond the Standard ModelB-meson decays; p(p)over-bar collisions; branching fraction; root-s=1.96 tev; search; mu(+)mu(-); b-0; b-s(0); violation; modelsLarge Hadron Collider (LHC)High Energy Physics - ExperimentSettore FIS/04 - Fisica Nucleare e SubnucleareNeutral currentCOLLIDER[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]uncertainty12.60.-iFlavour Physicmass spectrometryPhysicsExperimental particleMultidisciplinaryCMSMedicine (all)Temel BilimlerSettore FIS/01 - Fisica SperimentaleB-meson decaysATLASLarge Hadron Collider beautybranching ratio: measured [B/s0]root-s=1.96 tevNatural Sciences (SCI)LHCNatural SciencesPARTICLEdata processingParticle Physics - Experimentchemical reactionParticle physicsbranching fractionNOPARTICLE PHYSICS; LARGE HADRON COLLIDER; CMS; LHCBmodelsLHCBExperimental particle; physics; data processing; electromagnetic field; electromagnetic radiation; fundamental particle; Gaussian method; physics; precision; chemical analysis; chemical analyzer; chemical reaction; elementary particle; Large Hadron Collider beauty; mass spectrometry; meson; null hypothesis; prediction; priority journal; probability; radioisotope decay; standard; uncertainty;B-MESON DECAYSelectromagnetic fieldTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITYRare Decay0103 physical sciencesElectromagnetic fieldB-0elementary particleSDG 7 - Affordable and Clean EnergyDETECTORCompact Muon SolenoidMultidisipliner/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyLHCb DETECTORCMS LHC Meson B Rare DecayMinimal flavor violationpredictionLeptonsLHC-Bleptonic decay [B/s0]LHCbRare decayMedicine (all) MultidisciplinaryRARE B-MESON DECAYS; MINIMAL FLAVOR VIOLATION; LHC; CMS DETECTOR; LHCb DETECTOR; SEARCH; MU(+)MU(-); B-S(0); B-0B-S(0)[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]High Energy Physics::ExperimentExperimentsexperimental resultsCMS DETECTOR
researchProduct